Log In
BCIQ
Print this Print this
 

hydrocodone (Zohydro ER with BeadTek)

  Manage Alerts
Collapse Summary General Information
Company Pernix Therapeutics Holdings Inc.
DescriptionOral controlled-release formulation of hydrocodone that uses BeadTek, an inactive ingredient that forms a viscous gel when crushed and dissolved in solvents
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationPain
Indication DetailsManage pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$383.5M

$30.0M

$283.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/10/2015

$383.5M

$30.0M

$283.5M

Get a free BioCentury trial today